Am J Perinatol 2017; 34(12): e1-e2
DOI: 10.1055/s-0037-1603350
Erratum
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Erratum: Noninvasive Ventilation in Newborns ≤ 1,500 g after Tracheal Extubation: Randomized Clinical Trial

Simone Nascimento Santos Ribeiro
1   Section of Physiotherapy, Hospital Sofia Feldman, Belo Horizonte, MG, Brazil
,
Maria Jussara Fernandes Fontes
2   Department of Medicine, Federal University Minas Gerais, Belo Horizonte, MG, Brazil
,
Vineet Bhandari
3   Section of Neonatology, St. Christopher's Hospital for Children/Drexel University, Philadelphia, Pennsylvania
,
Camilla Borges Resende
4   Respiratory Care, Belo Horizonte, MG, Brazil
,
Cintia Johnston
5   Respiratory Care, Department of Pediatrics, Federal University São Paulo, São Paulo, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
10. Mai 2017 (online)

It has been brought to the publisher's attention that there were some errors in [Table 1] in the above article in the American Journal of Perinatology, published online on April 18, 2017 (DOI: 10.1055/s-0037-1602141). The correct [Table 1] appears as follows:

Table 1

Demographic and clinical data in the study groups

Features

NIPPV

(n = 36)

NCPAP bubble

(n = 33)

NCPAP ventilator

(n = 32)

p Value

Prenatal visits performed, n (%)

35 (97.2)

32 (97)

31 (96.9)

1.00

Antenatal corticosteroids, n (%)

32 (88.9)

28 (84.8)

31 (96.9)

1.00

 Dose

1.00

  Complete course, n (%)

30 (83.3)

27 (81.8)

26 (81.3)

  Incomplete course, n (%)

6 (16.7)

6 (18.2)

6 (18.8)

Cesarean deliveries, n (%)

19 (52.7)

15 (45.4)

14 (43.7)

0.38

Chorioamnionitis, n (%)

2 (5.6)

6 (18.2)

5 (15.6)

0.23

Antibiotics (antenatal), n (%)

12 (33.3)

9 (27.3)

14 (43.8)

0.27

Magnesium sulfate (antenatal), n (%)

19 (52.8)

16 (48.5)

9 (28.1)

0.09

Maternal age, mean ± SD

27.5 ± 6.24

25.91 ± 6.23

28.06 ± 7.22

0.55

Gestational age, mean ± SD

29.28 ± 1.7

29.82 ± 1.91

29.58 ± 1.96

0.39

Sex, n (%)

0.10

 Male

24 (66.7)

15 (45.5)

14 (43.8)

 Female

12 (33.3)

18 (54.5)

18 (56.3)

Weight, mean ± SD, g

1,121.53 ± 232.81

1,161.64 ± 225.07

1,154.20 ± 212.04

0.49

Apgar 1, median (min-max)

7 (5–8)

8 (6–8)

7 (6–8)

0.83

Apgar 5, median (min-max)

9 (8–9)

9 (8–9)

9 (8–9)

0.95

Time to surfactant administration, Mid h:m

1:57

2:00

1:50

0.74

Postnatal age (hours; mean ± SD) at the time of surfactant administration

1.96 ± 0.78

2.10 ± 0.92

2.05 ± 0.1.15

0.83

Time to extubation, median, d

RDS, n (%)

4

3

3

0.94

 Mild

17 (47.2)

17 (51.5)

14 (43.8)

0.54

 Moderate

9 (25)

12 (36.4)

11 (34.4)

 Severe

10 (27.8)

4 (12.1)

7 (21.9)

Surfactant dose, n (%)

0.19

 1 Dose

33 (91.7)

33 (100)

28 (87.5)

 2 Doses

3 (8.3%)

0

3 (9.4)

 3 Doses

0

0

1 (3.1)

Postnatal corticosteroid treatment, median, n

4

3

3

Ventilator settings before extubation, mean ± SD

0.94

FiO2 (%)

0.23 ± 0.04

0.23 ± 0.04

0.23 ± 0.04

0.79

PIP (cm H2O)

14.3 ± 0.5

14.4 ± 0.5

14.4 ± 0.5

0.37

PEEP (cm H2O)

4.5 ± 0.5

4.5 ± 0.5

4.6 ± 0.5

0.77

Ventilator rate (breaths/min)

24.7 ± 2.4

25.3 ± 2.4

26.7 ± 1.7

0.00[a]

IT (s)

0.30 ± 0.0

0.31 ± 0.0

0.30 ± 0.0

0.07

MAP (cm H2O)

6.4 ± 0.9

6.3 ± 0.9

6.5 ± 0.8

0.34

Flow (L/min)

6.1 ± 0.4

6.0 ± 0.3

6.0 ± 0.3

0.99

Abbreviations: cm H2O, centimeters of water; FiO2, fraction of inspired oxygen; IT, inspiratory time; MAP, mean airway pressure; NCPAP, nasal continuous positive airway pressure; NIPPV, nasal intermittent positive-pressure ventilation; PEEP, positive end expiratory pressure; PIP, peak inspiratory pressure; RDS, respiratory distress syndrome; SD, standard deviation.


a p value < 0.05.